Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322

  • Yoshitaka Zenke, Seiji Niho, Shigeki Umemura, Masashi Ishihara, Nobuhiko Seki, Naoyuki Nogami, Yukio Hosomi, Tsuneo Shimokawa, Takaaki Tokito, Yasushi Goto, Yosuke Miura, Haruhiro Saito, Naoya Hida, Satoshi Ikeda, Hiroshi Tanaka, Naoki Furuya, Toshihiro Misumi, Takeharu Yamanaka, Yuichiro Ohe, Hiroaki Okamoto
  • Lung Cancer, August 2020, Elsevier
  • DOI: 10.1016/j.lungcan.2020.05.005

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.lungcan.2020.05.005

The following have contributed to this page: Satoshi Ikeda